Varda appoints Mikael Dolsten to its board
Varda Space Industries →Varda announced the appointment of Mikael Dolsten to its board of directors. Dolsten previously served as Pfizer's Chief Scientific Officer and President of Research and Development, with experience across drug discovery, clinical development, regulatory approval and commercialization. Varda said his experience would support the company's effort to translate orbital pharmaceutical processing into medicines for terrestrial use. Co-Founder and Board Chairman Delian Asparouhov described the appointment as relevant to the transition from technology demonstrations toward drug development. The release presented commercial medicines made in space as an objective, rather than an accomplished regulatory milestone. Varda continued to describe its business as combining orbital processing with capsule reentry capabilities.